1. A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate‐to‐severe psoriasis. (1st June 2016) Authors: Papp, K.A.; Menter, M.A.; Raman, M.; Disch, D.; Schlichting, D.E.; Gaich, C.; Macias, W.; Zhang, X.; Janes, J.M. Journal: British journal of dermatology Issue: Volume 174:Number 6(2016) Page Start: 1266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate‐to‐severe psoriasis. (5th April 2016) Authors: Papp, K.A.; Menter, M.A.; Raman, M.; Disch, D.; Schlichting, D.E.; Gaich, C.; Macias, W.; Zhang, X.; Janes, J.M. Journal: British journal of dermatology Issue: Volume 174:Number 6(2016) Page Start: 1266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Psychometric properties of the Itch Numeric Rating Scale in patients with moderate‐to‐severe plaque psoriasis. (1st July 2016) Authors: Kimball, A.B.; Naegeli, A.N.; Edson‐Heredia, E.; Lin, C.‐Y.; Gaich, C.; Nikaï, E.; Wyrwich, K.; Yosipovitch, G. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Psychometric properties of the Itch Numeric Rating Scale in patients with moderate‐to‐severe plaque psoriasis. (8th May 2016) Authors: Kimball, A.B.; Naegeli, A.N.; Edson‐Heredia, E.; Lin, C.‐Y.; Gaich, C.; Nikaï, E.; Wyrwich, K.; Yosipovitch, G. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Psychometric properties of the Itch Numeric Rating Scale in patients with moderate‐to‐severe plaque psoriasis3. (8th May 2016) Authors: Kimball, A.B.; Naegeli, A.N.; Edson‐Heredia, E.; Lin, C.‐Y.; Gaich, C.; Nikaï, E.; Wyrwich, K.; Yosipovitch, G. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0609 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis and An Inadequate Response To Background Methotrexate Therapy. (15th July 2016) Authors: Keystone, E.; Taylor, P.; Tanaka, Y.; Gaich, C.; DeLozier, A.M.; Dudek, A.; Velasco Zamora, J.; Covarrubias Cobos, J.; de Bono, S.; Arora, V.; Yang, L.; Linetzky, B.; Weinblatt, M.E. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0617 Work Productivity and Daily Activity in Patients with Rheumatoid Arthritis in Four Phase III Randomized Clinical Trials of Baricitinib. (15th July 2016) Authors: Smolen, J.S.; DeLozier, A.M.; de Bono, S.; Yang, L.; Gaich, C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0623 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib in Patients with Early Rheumatoid Arthritis Who Had Received Limited or No Treatment with Disease-Modifying anti-Rheumatic Drugs. (15th July 2016) Authors: Schiff, M.; Takeuchi, T.; Gaich, C.; DeLozier, A.M.; Schlichting, D.; Kuo, W.-L.; Durez, P.; Carmack, T.; Won, J.-E.; Fleischmann, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗